XOMO vs. GNOM

Last updated Jun 24, 2026

XOMO (YieldMax XOM Option Income Strategy ETF) and GNOM (Global X Genomics & Biotechnology ETF) are both exchange-traded funds - XOMO is a Derivative Income fund actively managed by YieldMax, while GNOM is a Health & Biotech Equities fund tracking the Solactive Genomics Index. XOMO is actively managed, while GNOM is passively managed. Over the past year, XOMO returned 16.88% vs 61.83% for GNOM. At a 0.00 correlation, their price movements are largely independent. XOMO charges 1.01%/yr vs 0.50%/yr for GNOM.

Performance

XOMO vs. GNOM - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in YieldMax XOM Option Income Strategy ETF (XOMO) and Global X Genomics & Biotechnology ETF (GNOM). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

In the year-to-date period, XOMO achieves a 10.22% return, which is significantly lower than GNOM's 14.90% return.

XOMO

• 1D: 0.93%
• 1M: -6.78%
• YTD: 10.22%
• 6M: 11.32%
• 1Y: 16.88%
• 3Y*: —
• 5Y*: —
• 10Y*: —

GNOM

• 1D: 0.90%
• 1M: 12.22%
• YTD: 14.90%
• 6M: 11.42%
• 1Y: 61.83%
• 3Y*: 2.88%
• 5Y*: -11.06%
• 10Y*: —

*Multi-year figures are annualized to reflect compound growth (CAGR)

XOMO vs. GNOM - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023
XOMO YieldMax XOM Option Income Strategy ETF	10.22%	6.90%	6.11%	-8.59%
GNOM Global X Genomics & Biotechnology ETF	14.90%	18.65%	-15.99%	1.92%

Correlation

The correlation between XOMO and GNOM is -0.27, meaning they tend to move in opposite directions. This is especially valuable for risk management - when one declines, the other has historically tended to hold steady or rise.

	Correlation
Correlation (1Y) Calculated over the trailing 1-year period	-0.27
Correlation (All Time) Calculated using the full available price history since Aug 31, 2023	0.00

The correlation between XOMO and GNOM shifts across timeframes, from -0.27 (1 year) to 0.00 (all time), reflecting how their relationship changes across market environments.

Return for Risk

XOMO vs. GNOM — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

XOMO

XOMO Risk / Return Rank: 23
XOMO Sharpe Ratio Rank: 24
XOMO Sortino Ratio Rank: 22
XOMO Omega Ratio Rank: 23
XOMO Calmar Ratio Rank: 22
XOMO Martin Ratio Rank: 24

GNOM

GNOM Risk / Return Rank: 68
GNOM Sharpe Ratio Rank: 76
GNOM Sortino Ratio Rank: 74
GNOM Omega Ratio Rank: 63
GNOM Calmar Ratio Rank: 71
GNOM Martin Ratio Rank: 58

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

XOMO vs. GNOM - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for YieldMax XOM Option Income Strategy ETF (XOMO) and Global X Genomics & Biotechnology ETF (GNOM). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.

	XOMO	GNOM	Difference
Sharpe ratio: Return per unit of total volatility	0.83	2.28	-1.45
Sortino ratio: Return per unit of downside risk	1.19	3.11	-1.91
Omega ratio: Gain probability vs. loss probability	1.16	1.36	-0.20
Calmar ratio: Return relative to maximum drawdown	1.01	3.42	-2.41
Martin ratio: Return relative to average drawdown	2.99	9.81	-6.82

XOMO vs. GNOM - Sharpe Ratio Comparison

The current XOMO Sharpe Ratio is 0.83, which is lower than the GNOM Sharpe Ratio of 2.28. The chart below compares the historical Sharpe Ratios of XOMO and GNOM, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Drawdowns

XOMO vs. GNOM - Drawdown Comparison

The maximum XOMO drawdown since its inception was -18.90%, smaller than the maximum GNOM drawdown of -75.00%. Use the drawdown chart below to compare losses from any high point for XOMO and GNOM.

Drawdown Indicators

	XOMO	GNOM	Difference
Max Drawdown Largest peak-to-trough decline	-18.90%	-75.00%	+56.10%
Max Drawdown (1Y) Largest decline over 1 year	-16.86%	-18.17%	+1.31%
Max Drawdown (3Y) Largest decline over 3 years	—	-44.24%	—
Max Drawdown (5Y) Largest decline over 5 years	—	-72.29%	—
Current Drawdown Current decline from peak	-15.29%	-52.52%	+37.23%
Average Drawdown Average peak-to-trough decline	-7.31%	-40.63%	+33.32%
Ulcer Index Depth and duration of drawdowns from previous peaks	5.66%	6.32%	-0.66%

Volatility

XOMO vs. GNOM - Volatility Comparison

The current volatility for YieldMax XOM Option Income Strategy ETF (XOMO) is 7.49%, while Global X Genomics & Biotechnology ETF (GNOM) has a volatility of 9.34%. This indicates that XOMO experiences smaller price fluctuations and is considered to be less risky than GNOM based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	XOMO	GNOM	Difference
Volatility (1M) Calculated over the trailing 1-month period	7.49%	9.34%	-1.85%
Volatility (6M) Calculated over the trailing 6-month period	17.38%	20.57%	-3.19%
Volatility (1Y) Calculated over the trailing 1-year period	20.65%	27.29%	-6.64%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	19.13%	33.68%	-14.55%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	19.13%	34.17%	-15.04%

XOMO vs. GNOM - Expense Ratio Comparison

XOMO has a 1.01% expense ratio, which is higher than GNOM's 0.50% expense ratio.

Dividends

XOMO vs. GNOM - Dividend Comparison

XOMO's dividend yield for the trailing twelve months is around 37.38%, more than GNOM's 1.20% yield.

Position	TTM	2025	2024	2023	2022	2021	2020
GNOM Global X Genomics & Biotechnology ETF	1.20%	1.37%	0.00%	0.00%	0.00%	0.03%	0.14%
XOMO YieldMax XOM Option Income Strategy ETF	37.38%	31.64%	26.94%	5.13%	0.00%	0.00%	0.00%

Frequently Asked Questions

Can I hold both XOMO and GNOM in my portfolio?

XOMO and GNOM have a correlation of -0.27, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Which is riskier, XOMO or GNOM?

GNOM has higher volatility (9.34%) compared to XOMO (7.49%). In terms of maximum drawdown, XOMO dropped -18.90% vs GNOM's -75.00%.

Which ETF is better, XOMO or GNOM?

On 1-year performance, GNOM leads with 61.83% vs 16.88% for XOMO. On fees, GNOM is cheaper at 0.50% per year. On volatility, XOMO has been the lower-risk option at 7.49%. The better choice depends on whether you care most about return, fees, risk, or income.

Which ETF has performed better, XOMO or GNOM?

Over the 1-year period, GNOM has performed better with a 61.83% return vs 16.88%. Past performance does not guarantee future results, so compare this with risk, fees, and fund exposure.

Which ETF is cheaper, XOMO or GNOM?

GNOM is cheaper with a 0.50% expense ratio, compared with 1.01% for XOMO.

Which ETF pays a higher dividend yield, XOMO or GNOM?

XOMO has the higher dividend yield at 37.38%, compared with 1.20% for GNOM.

What is the main difference between XOMO and GNOM?

XOMO is categorized as Derivative Income, while GNOM is Health & Biotech Equities. They also come from different issuers: YieldMax and Global X. Their fees differ too: 1.01% for XOMO and 0.50% for GNOM.

Which has better risk-adjusted returns?

GNOM currently has the higher Sharpe Ratio (2.28 vs 0.83), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.